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Support of ageing neurons by endogenous neurotrophic factors such as glial cell line–derived neurotrophic factor
(GDNF) and brain-derived neurotrophic factor (BDNF) may determine whether the neurons resist or succumb to
neurodegeneration. GDNF has been tested in clinical trials for the treatment of Parkinson disease (PD), a common
neurodegenerative disorder characterized by the loss of midbrain dopaminergic (DA) neurons. BDNF modulates
nigrostriatal functions and rescues DA neurons in PD animal models. The physiological roles of GDNF and BDNF
signaling in the adult nigrostriatal DA system are unknown. We generated mice with regionally selective ablations of
the genes encoding the receptors for GDNF (Ret) and BDNF (TrkB). We find that Ret, but not TrkB, ablation causes
progressive and adult-onset loss of DA neurons specifically in the substantia nigra pars compacta, degeneration of DA
nerve terminals in striatum, and pronounced glial activation. These findings establish Ret as a critical regulator of long-
term maintenance of the nigrostriatal DA system and suggest conditional Ret mutants as useful tools for gaining
insights into the molecular mechanisms involved in the development of PD.
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Introduction
The ventral mesencephalon contains the majority of
dopaminergic (DA) neurons in the vertebrate brain with
important functions for maintaining the mental and physical
health of the organism. They form two prominent pathways:
DA neurons of the substantia nigra pars compacta (SNpc)
extend their axons mainly into the dorsal striatum (caudate-
putamen) to form the nigrostriatal pathway essential for the
control of voluntary motor behavior. DA neurons of the
ventral tegmental area (VTA) project their fibers mostly into
the ventral striatum (nucleus accumbens), olfactory tubercle,
septum, amygdala, hippocampus, and cortex collectively
referred to as the mesocorticolimbic system. This system
has important function in controlling emotion-based behav-
ior such as motivation and reward. Pathological changes in
the DA systems result in psychosis, schizophrenia, attention
deficit/hyperactivity disorder (ADHD), depression, addiction,
and, most prominently, Parkinson disease (PD).
PD is the most common neurodegenerative movement
disorder, clinically characterized by resting tremor, rigidity,
postural imbalance, and bradykinesia. The underlying patho-
logical event in PD is the progressive loss of DA neurons in
the SNpc, often accompanied by intracytoplasmic proteina-
ceous inclusions termed Lewy bodies [1] and by neuroinflam-
matory processes [2]. Because of presymptomatic
compensation [3], behavioral symptoms appear by a thresh-
old effect, when 50%–60% of SNpc neurons and 70%–80%
of striatal dopamine are lost [4,5]. Healthy individuals also
experience continuous loss of DA neurons, but they remain
asymptomatic as long as the critical threshold is not reached.
The questions about the molecular etiology of PD and the
selective neuronal vulnerability have not been answered
satisfactorily.
Endogenous neurotrophic factors regulate natural cell
death during development and maintain target innervations
and cell survival during postnatal life. Declining production
of a neurotrophic factor or impaired signal transduction in
ageing neurons may contribute to pathological neurodegen-
eration [6]. Glial cell line–derived neurotrophic factor
(GDNF) is a member of the GDNF family of neurotrophic
factors that signal through a two-component receptor
complex consisting of the Ret (rearranged during trans-
fection) receptor tyrosine kinase and the GPI-linked GDNF
family receptor alphas (GFRa) [7]. GDNF was suggested to be
a target-derived neurotrophic factor for developing DA
Academic Editor: Richard G. M. Morris, University of Edinburgh, United Kingdom
Received June 12, 2006; Accepted December 7, 2006; Published February 13,
2007
Copyright:  2007 Kramer et al. This is an open-access article distributed under
the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author
and source are credited.
Abbreviations: BDNF, brain-derived neurotrophic factor; CNS, central nervous
system; DA, dopaminergic; FSCV, fast-scan cyclic voltammetry; GDNF, glial cell line–
derived neurotrophic factor; GFAP, glial fibrillary acidic protein; Iba, ionized binding
calcium adapter molecule; LC, locus coeruleus; PD, Parkinson disease; SNpc,
substantia nigra pars compacta; TH, tyrosine hydroxylase; VTA, ventral tegmental
area
* To whom correspondence should be addressed. E-mail: rklein@neuro.mpg.de
(RK), ekramer@neuro.mpg.de (ERK)
PLoS Biology | www.plosbiology.org March 2007 | Volume 5 | Issue 3 | e390616
PLoS BIOLOGY
neurons [8] and a postnatal survival factor for midbrain DA
neurons (reviewed in [9,10]). Genetic evidence, however, is
limited, because GDNF and Ret null mutant mice die at birth
[10]. GDNF protects DA neurons from the effects of neuro-
toxins such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP) (reviewed in [7,11]). GDNF is currently tested in
clinical trials (using different delivery systems) with the hope
that it will ameliorate PD symptoms, but the results are so far
conflicting [12,13]; see also [14] and [15].
Brain-derived neurotrophic factor (BDNF) is a member of
theneurotrophin family and signals through theTrkB receptor
tyrosine kinase and the p75 receptor. BDNF and TrkB are
widely expressed throughout the adult and ageing brain,
including midbrain DA neurons and the striatum [16,17], but
age- and PD-related decreases in the expression of BDNF and
reduced responsiveness to BDNF have been observed (re-
viewed in [6,18]). DA neuron loss after BDNF ablation during
development [19] suggested that impaired signaling through
TrkB may compromise DA neuron survival. BDNF modulates
nigrostriatal functions and rescues DA neurons in PD animal
models [9,20,21]. BDNF and TrkB null mutant mice do not
survive to adulthood, preventing the genetic analysis of their
roles in long-term DA neuron survival [22,23].
To investigate the physiological requirements for Ret and
TrkB to establish and maintain the nigrostriatal pathway, we
generated mice with regionally selective Ret and TrkB
ablations that are compatible with postnatal survival of the
mice. We find that Ret, but not TrkB, regulates long-term
maintenance of the nigrostriatal DA system. Ret ablation
causes progressive and late loss of DA neurons in SNpc,
degeneration of DA nerve terminals in striatum, pronounced
reactive gliosis, microglial activation, and reduced levels of
evoked dopamine release. Together, these data establish Ret
as an important signaling receptor for nigrostriatal DA
system preservation and suggest conditional Ret mutants as
an interesting model to study presymptomatic compensatory
mechanisms in this system and early PD-related pathologies.
Results
Generation of Mice Lacking Ret and TrkB Receptors in
SNpc DA Neurons
To disrupt the genes encoding Ret and TrkB in a regionally
selective manner, we used mice with floxed alleles of Ret [24]
and TrkB [25] in combination with Dopamine transporter (DAT)-
Cre mice [26] (DAT-Retlx/lx and DAT-TrkBlx/lx mice, respectively)
and Nestin-Cre mice [27] (Nes-Retlx/lx mutants). DAT-Cre mice
had been generated by knocking Cre into the 59 UTR region
of the endogenous mouse DAT locus [26], whereas Nestin-Cre
mice express Cre from a transgene [27]. For DAT-Cre mice, it
was previously shown that virtually all (95%) of tyrosine
hydroxylase (TH)-positive cells in SNpc and the nearby VTA
regions express Cre and show Cre-mediated recombination
in adult mice, whereas weak lacZ reporter activity was seen in
DA neurons of the olfactory bulb and hypothalamus. No
reporter activity was seen in the striatum [26]. We confirmed
these observations and extended the analysis to other time
points, including embryonic day 15 and 2-y postnatal (Figure
1A–1D). Our results indicate that DAT-Cre–mediated re-
combination is region selective from late embryonic stages to
aged mice. Ret expression is high in the SNpc and VTA of
adult control mice (Figure 1E and 1F) and is efficiently
removed in DAT-Retlx/lx and Nestin-Retlx/lx mice (Figure 1G–1J).
Western blot analysis of Ret protein revealed a nearly
complete loss of the protein in SN of Dat-Retlx/lx mice, and
complete loss of Ret in the striatum of DAT-Retlx/lx mice
(Figure 1K and 1L). TrkB expression is found in nigral DA
neurons [17], but also in other neuronal populations in the
entire ventral midbrain (unpublished data). The conditional
trkBlx allele has previously been used for region-specific
removal of TrkB in several studies [25,28], indicating that this
locus can efficiently be modified by Cre recombination. We
were unable to visualize loss of TrkB by immunostaining and
Western blotting in DAT-TrkBlx/lx mice, because the TH-
positive subpopulation expresses low amounts of TrkB and is
a minor population within the TrkB expression domain.
However, we detected the recombined TrkBlx allele by PCR
specifically in SNpc, but not in striatum, of DAT-TrkBlx/lx mice
(Figure S1A). In addition, using laser capture microdissection
combined with single-cell RT-PCR, we found a 65% decrease
of TrkB mRNA–positive DA neurons in the SNpc in DAT-
TrkBlx/lx mice compared to controls (Figure S1B–S1D).
Substantial Loss of Midbrain DA Neurons in Aged DAT-
Retlx/lx Mice
DAT-Retlx/lx and DAT-TrkBlx/lx knock-outs are viable and
fertile. To detect morphological alterations in the nigros-
triatal system, brain tissue sections of mutant and control
mice (floxed Ret and/or TrkB mice; heterozygote DAT-Cre
mice) were immunostained for TH and subjected to stereo-
logical quantification (Figure 2A). A significant decrease of
approximately 25% in the number of TH-positive neurons in
the SNpc was found in 1-y-old DAT-Retlx/lx, but not DAT-
TrkBlx/lx mice, compared to age-matched control mice (Figure
2B). Similar reductions of SNpc neurons were also observed
in a more widespread knock-out of Ret using Nestin-Cre mice
(Figure 2C). Combined loss of Ret and TrkB did not
significantly enhance the loss of TH-positive neurons,
suggesting that TrkB signaling has a minor, if any, role in
the survival of a subset of nigral DA neurons (Figure 2B). A
Author Summary
What does a neuron need to survive? Our body produces its own
survival factors for neurons, so-called neurotrophic factors, which
have additional roles in neuron differentiation, growth, and function.
Declining production of a neurotrophic factor or impaired signal
transduction in ageing neurons may contribute to pathological
neurodegeneration in humans. Glial cell line–derived neurotrophic
factor (GDNF) and brain-derived neurotrophic factor (BDNF) have
been suggested as survival factors for midbrain dopaminergic
neurons, a group of neurons primarily affected in Parkinson disease.
To investigate the physiological requirements for GDNF and BDNF
to establish and maintain an important output pathway of these
neurons—the nigrostriatal pathway—in the intact brain, we
generated mutant mice with regionally selective ablations of the
receptors for these survival factors, Ret (receptor of GDNF and
related family members) or TrkB (BDNF receptor). Surprisingly, these
mice survive to adulthood and show normal development and
maturation of the nigrostriatal system. However, in ageing mice,
ablation of Ret leads to a progressive and cell-type–specific loss of
substantia nigra pars compacta neurons and their projections into
the striatum. Our findings establish Ret and subsequent down-
stream effectors as critical regulators of long-term maintenance of
the nigrostriatal system.
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time-course analysis starting at 3 mo of age revealed that the
nigrostriatal system of DAT-Retlx/lx mutants had developed
normally, despite the fact that DAT-Cre–mediated recombi-
nation started during late embryogenesis (Figure 2B). At 2 y
of age, DAT-Retlx/lx mice have lost 38% of TH-positive
neurons, compared to age matched control mice (Figure
2B), whereas in 2-y-old DAT-TrkBlx/lx mice, no reduction of
TH-positive neurons was detected (Figure 2B). We used the
general neuronal marker NeuN and additional independent
markers of nigral DA neurons to further characterize the
defects in DAT-Retlx/lx mutants. Anti-NeuN immunostaining
combined with a weak TH staining to visualize the SNpc
revealed 14% and 17% loss of NeuN-positive cells in the
SNpc of 1-y-old and 2-y-old DAT-Retlx/lx mutants, respectively
(Figure 2D and 2E). Nissl staining, which labeled approx-
imately five times more cells than TH staining, did not reveal
significant changes in DAT-Retlx/lx mutants (Figure S2A–S2C).
Anti–dopa-decarboxylase (DDC) and anti-Pitx3 immunos-
taining [29] revealed reductions of 35%–40% of immuno-
positive nigral DA neurons in DAT-Retlx/lx mutants compared
to controls (Figure 2F–2J). In summary, the data suggest that
loss of Ret leads to the loss of neurons rather than to reduced
TH expression in a subpopulation of the SNpc. The observed
defects in Ret mutants were region specific: The nearby VTA
region was not affected in DAT-Retlx/lx mice, and the locus
coeruleus (LC) was not affected in Nes-Retlx/lx mutants (despite
the fact that Nestin-Cre recombines in and Ret is expressed in
the LC) (Figure 2K and 2L). The loss of SNpc DA neurons in
PD is often associated with the formation of a-synuclein–
containing aggregates, so-called Lewy bodies. We were not
able to detect accumulation or aggregates of a-synuclein in
the cell bodies of Ret or TrkB or double-mutant mice (Figure
S3A–S3I and unpublished data).
Loss of DA Nerve Terminals in the Striatum of Aged DAT-
Retlx/lx Mutants
We next sought to evaluate the possibility that Ret and
TrkB signaling would be required for maintenance of target
innervation of nigral DA neurons. The quantification of TH-
positive fiber density revealed an approximately 40%
decrease in the dorsal striatum of 1-y-old DAT-Retlx/lx mice,
compared to age-matched controls (floxed Ret and/or TrkB
mice; heterozygote DAT-Cre mice) or DAT-TrkBlx/lx knock-
outs (Figure 3A–3E). Similar reductions in TH fiber density
(38%) were seen in 1-y-old DAT-Ret/TrkB double knock-outs
and in Nestin-Retlx/lx mutants (Figure 3E). The reduction was
Figure 1. Conditional Ablation of Ret Expression in the Nigrostriatal
System
(A–D) Recombination efficiency of DAT-Cre mice crossed with Rosa26R
lacZ reporter mice (DAT-Rosa26R). b-galactosidase (X-Gal) activity (blue)
in coronal brain sections of DAT-Rosa26R transgenic mice at embryonic
day E15.5 (A) and at 3-mo postnatal (B). Anti- TH (C) and anti–b-
galactosidase (b-Gal) (D) immunostaining in adjacent brain sections of 2-
y-old DAT-Rosa26R mice. Cre activity is restricted to SNpc and VTA.
(E–J) Immunohistochemical detection of TH (E, G, and I) and Ret (F, H,
and J) in adjacent coronal brain sections of 3-mo-old wild-type (wt), DAT-
Retlx/lx, and Nes-Retlx/lx mice. Note the nearly complete removal of Ret
immunoreactivity in SNpc and VTA of DAT-Retlx/lx and Nes-Retlx/lx mice.
(K and L) Western blot analysis of Ret protein levels in protein lysates
from SNpc (K) and striatum (L) of 3-mo-old control (Retlx/þand DAT-Retlx/þ)
and DAT-Retlx/lx mutant mice. Immunoblots were reprobed with anti–a-
tubulin antibodies as loading controls.
doi:10.1371/journal.pbio.0050039.g001
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somewhat more pronounced in dorsal versus ventral striatum
(40% versus 28% in DAT-Retlx/lx mice, and 38% versus 20% in
DAT-Ret/TrkB double-mutant mice and Nestin-Retlx/lx mutants),
correlating with the innervation preference by nigral DA
neurons [30] (Figure 3E, ventral). To exclude the possibility
that the reduction of TH fiber density reflected a reduction of
TH protein, rather than fibers, we used DAT protein as an
independent and selective marker for DA terminals. Because
the aged DAT-Cre knock-in mice have reduced levels of DAT
protein (unpublished data) due to the loss of one functional
copy of the DAT gene, we analyzed Nes-Retlx/lx instead and
found a similar reduction of DAT fiber density in mutants
versus control mice (Figure 3F–3H). A time-course analysis
between 3 mo and 2 y revealed that this was an age-
dependent process that started at around 9 mo of age and was
most pronounced in 2-y-old mice (63% reduction in DAT-
Figure 2. Progressive Loss of Nigral DA Neurons in DAT-Retlx/lx Mice
(A) Coronal brain section of a 3-mo-old wild-type mouse showing DA neurons in the SNpc and the VTA stained with an antibody against TH. The inset
shows a higher magnification view of the stippled area.
(B and C) Stereological quantification of TH-positive DA neurons in the SNpc of 3-, 12-, and 24-mo-old control, DAT-TrkBlx/lx, DAT-Retlx/lx, and double
homozygous Dat-Ret/TrkB mice (C) (n¼ 3 mice per genotype), Nes-Retlx/lx mutant mice and littermate controls (D) (n¼ 4 mice per genotype). *, p , 0.05
(Student t-test).
(D) Double immunostaining for NeuN and TH (very mild staining protocol to outline the SNpc [stippled area]). The inset shows a higher magnification
view of the stippled box, displaying nuclear localization for NeuN and cytoplasmic immunoreactivity for TH.
(E) Stereological quantification of NeuN-positive neurons in the SNpc of 12- and 24-mo-old control and DAT-Retlx/lx mice (n¼ 5 mice per genotype at 12
mo, and n ¼ 4 mice per genotype at 24 mo). *, p , 0.0001 and p , 0.001 for 12- and 24-mo-old DAT-Retlx/lx mice, respectively (Student t-test).
(F–H) Adjacent sections of SNpc and VTA of a 1-y-old wild-type mouse stained for TH (F), dopa-decarboxylase (G), and Pitx3 (H). Insets show higher
magnification images.
(I and J) Stereological quantification of DDC-positive (I) and Pitx3-positive (J) cells in the SNpc of 12-mo-old littermate control and DAT-Retlx/lx mice (n¼
3 mice per genotype). *, p , 0.05 (Student t-test).
(K and L) Stereological quantification of TH-positive cells in the VTA region of 1-y-old control and DAT-Ret/TrkBmutant mice (K) (n¼3 mice per genotype;
p . 0.5; Student t-test) and in the LC of 12-mo-old control and Nes-Retlx/lx mutant mice (L) (n¼ 4 mice per genotype; p .0.5; Student t-test). Scale bar
indicates 250 lm and, in insets, 100 lm.
doi:10.1371/journal.pbio.0050039.g002
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Retlx/lx mice versus controls) (Figure 3I). In conclusion, Ret
signaling is required for maintenance of target innervation of
midbrain DA neurons.
Non-Cell Autonomous Dysfunction of Striatal Neurons in
Aged DAT-Retlx/lx Mutants
We next asked if loss of nigrostriatal innervation by
midbrain DA neurons would cause non-cell autonomous
dysfunction of striatal target neurons that do not express Ret.
Staining with the neuronal marker NeuN, which detects all
striatal neurons including interneurons, revealed a decreased
staining intensity and a small, but significant reduction of
NeuN-positive cells (8%; n ¼ 5 for each group; p , 0.05,
Student t-test) in 2-y-old DAT-Retlx/lx compared to age-
matched control striatum (Figure 4A–4C). More importantly,
expression of DARPP-32 (dopamine and cyclic adenosine
39,59-monophosphate-regulated phosphoprotein, 32 kDa), a
protein expressed by nearly all dopaminoceptive striatal
projection neurons [30], was also reduced and the number of
positive cells decreased by 20% (n ¼ 3 for each group; p ,
0.01, Student t-test) in DAT-Retlx/lx mutants compared to
controls, suggesting the existence of postsynaptic dysfunction
including unhealthy, atrophic cells and perhaps cell loss as
consequence of Ret ablation in DA neurons (Figure 4D–4F).
In contrast, expression of the calcium-binding protein
parvalbumin, which labels local GABAergic interneurons,
Figure 3. Progressive Loss of Striatal Innervation in DAT-Retlx/lx, but Not DAT-TrkBlx/lx Mice
(A–D, F, and G) Representative images of dorsal striatum stained by immunofluorescence using antibodies against TH (A–D) and DAT (F and G) of
control (A, B, and F) and DAT-Retlx/lx mutants (C, D, and G) at 12 (A, C, F, and G) and 24 mo of age (B and D).
(E) The innervation density based on anti-TH immunofluorescence was quantified in dorsal versus ventral striatum of 12-mo-old controls (n¼ 16) versus
DAT-TrkBlx/lx (n¼ 4), DAT-Retlx/lx (n¼ 6), double DAT-Ret/TrkB (n¼ 5), and Nes-Retlx/lx mutants (n¼ 7). DAT-Retlx/lx, double DAT-Ret/TrkB, and Nes-Retlx/lx
mutants showed significant reductions in TH fiber density in dorsal (p , 0.001) and ventral striatum (p , 0.001, p , 0.01, and p , 0.01 for DAT-Retlx/lx,
double DAT-Ret/TrkB, and Nes-Retlx/lx mutants, respectively). **, p , 0.01 (Student t-test).
(H) The innervation density based on anti-DAT immunofluorescence was quantified in 12-mo-old Nes-Retlx/lx mutants compared to age-matched
controls (n¼ 4 per genotype; p , 0.001, Student t-test).
(I) Time course of TH-positive fiber loss from 3 to 24 mo of age. DAT-Retlx/lx mutant mice show a progressive fiber loss, starting at 6 to 9 mo (p¼0.09 and
p, 0.05 at 6 mo and 9 mo, respectively) and maximizing at 24 mo (p, 0.0001). DAT-TrkBlx/lx mutant mice do not show any signs of fiber loss even at 24
mo of age (p ¼ 0.13). *, p , 0.05; **, p , 0.01 (Student t-test). Scale bar indicates 25 lm.
doi:10.1371/journal.pbio.0050039.g003
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was not reduced in DAT-Retlx/lx mutants compared to controls
(Figure 4G–4I). These results suggest that loss of nigrostriatal
innervation indirectly affects a fraction of dopaminoceptive
striatal neurons.
Gliosis in Dorsal Striatum of DAT-Retlx/lx Mice
Having established substantial loss of nigrostriatal inner-
vation and some striatal dysfunction in DAT-Retlx/lx mutants,
we next asked if these degenerative processes would cause
gliosis by invading reactive astrocytes. We used immunor-
eactivity against glial fibrillary acidic protein (GFAP) as an
indicator of the astroglial response to genetically induced DA
nerve terminal damage (Figure 5). Staining of 2-y-old brains
revealed a massive reactive gliosis in dorsal striatum of DAT-
Retlx/lx mutants compared to controls (Figure 5D–5F; n ¼ 5
mice per group, p , 0.0001, Student t-test). No increased
GFAP immunoreactivity was observed in 2-y-old DAT-TrkBlx/lx
striatum (Figure 5F; n ¼ 4 per group, p , 0.0001, Student t-
test), or in younger (12-mo-old) DAT-Retlx/lx mutants (Figure
5A–5C; n ¼ 3 mice per group, p ¼ 0.90, Student t-test), or in
other brain regions such as the neocortex of 2-y-old DAT-
Retlx/lx mutants (unpublished data). GFAP immunoreactivity
in SNpc of 2-y-old DAT-Retlx/lx mutants was not significantly
enhanced compared to controls (Figure 5G–5I; n ¼ 3 per
group, p¼ 0.24, Student t-test) despite the marked loss of TH-
positive cells in this structure. Because Ret is not genetically
ablated in astrocytes, these results suggest that the gliosis in
the striatum of DAT-Retlx/lx mice is non-cell autonomously
caused by degenerating DA nerve terminals.
Inflammation in SNpc of DAT-Retlx/lx Mice
Inflammatory processes are often associated with and
activated by a variety of neuronal insults including PD and
Alzheimer disease. We used immunohistochemistry for ion-
ized binding calcium adapter molecule (Iba)-1 to detect
microglia in brains of DAT-Retlx/lx mice. The numbers of Iba-1
immunopositive cells were not significantly increased in
dorsal striatum of 2-y-old DAT-Retlx/lx mice compared to
controls (Figure 6A–6C; n ¼ 4 mice per group, p ¼ 0.065,
Student t-test). In contrast, we observed an approximately
45% increase in the number of Iba-1 immunopositive cells in
SNpc of 2-y-old DAT-Retlx/lx mice compared to controls and
DAT-TrkBlx/lx mice (Figure 6D–6J; n¼ 3 mice for DAT-TrkBlx/lx
and n¼ 5 mice for controls and DAT-Retlx/lx, p , 0.05, Student
t-test). Similar results were obtained using macrophage
antigen alpha (MAC1, CD11b, or CR3) as a second,
independent marker (Figure 6K–6M; n ¼ 3 mice per group,
p , 0.05, Student t-test). No differences in the numbers of
Iba-1–positive microglial cells were detected in 1-y-old DAT-
Retlx/lx mice compared to controls (unpublished data). Similar
to reactive astrocytes, the Ret gene was not subjected to
recombination in microglia of DAT-Retlx/lx mice, suggesting
that the neuroinflammation occurred as a result of neuronal
cell death.
Figure 4. Loss of Postsynaptic Target Cells but Not Local Striatal Interneurons in DAT-Retlx/lx Mice
Immunohistochemical stainings of dorsal striatumof 2-y-old control (A, D, andG) andDAT-Retlx/lxmutants (B, E, andH) for NeuN (A and B), DARPP-32 (D and
E), or parvalbumin (G and H). Histograms showing the number of NeuN-positive (C), DARPP-32–positive (F), and parvalbumin-positive cells (I) inDAT-Retlx/lx
mutants and age-matched controls (n¼3–5 each genotype). Note also the reduced staining intensities for NeuN andDARPP-32 inDAT-Retlx/lx compared to
control mice. *, p , 0.05; **, p, 0.01 (Student t-test). Scale bars indicate 50 lm.
doi:10.1371/journal.pbio.0050039.g004
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Reduced Dopamine Release in the Striatum of DAT-Retlx/lx
Mice
PD is clinically defined by a decrease in dopamine levels
that result in motor impairments. To determine the effects of
nerve terminal loss in DAT-Retlx/lx mice on the DA output
capacity of the system, we measured total levels and evoked
dopamine release in the striatum of mutant mice. Striatal
levels of dopamine and one of its major metabolites,
dihydroxyphenylacetic acid (DOPAC), were similar in DAT-
Retlx/lx and control mice at 3, 12, and 24 mo (Figure 7A and
unpublished data). The somewhat lower values in all mice
(mutants and controls) carrying the DAT-Cre transgene
compared to DAT-Cre–negative controls is due to the reduced
levels of DAT protein, which regulates dopamine transport
and metabolism [31]. Evoked dopamine release was measured
by fast-scan cyclic voltammetry (FSCV) following electrical
stimulation of coronal slice preparations of mutant and
control mice [32]. Electrical stimulation resulted in a stimulus
intensity–dependent overflow of DA in the striatum. DA
overflow is the result of released DA minus the DA reuptake
by DAT. We observed a marked reduction of evoked DA
overflow in the striatum of all mice carrying the DAT-Cre
transgene (Figure 7B–7E) as described before [31]. Interest-
ingly, the evoked DA overflow was further reduced in DAT-
Retlx/lx mice compared to DAT-Retlx/þcontrol mice in both 1-y-
old and 2-y-old mutants (n¼5 per genotype, p , 0.05 and p ,
0.01 for 1-y-old and 2-y-old mutants, respectively, one-way
analysis of variance and post-hoc Student t-test). Together
with the unchanged input–output curves of the FSCV
experiment (Figure S4), these data suggest that the reduced
dopamine release and reuptake in the Ret mutants is likely
due to the reduced number of DA fibers in the striatum. To
determine to what extent these histological and physiological
alterations change the behavior of the DAT-Retlx/lx mice, we
tested DAT-Retlx/lx and control mice for behavioral alterations
in open-field and rotarod tasks, and in voluntary and forced
swimming tasks (Protocol S1). The behavior was essentially
unaffected in the mutants (Figure S5).
Discussion
In the present study, we show that signaling by Ret and
TrkB receptors is not essential for establishment of the
nigrostriatal system. TrkB signaling appears to play a minor,
if any, role in maintaining long-term cell survival or target
innervation of midbrain DA neurons in aged mice. In
contrast, Ret ablation leads to a progressive and cell-type–
specific loss of SNpc neurons and their afferents with adult
onset, with subsequent alterations in physiology and appear-
ance of neuroinflammatory responses. These findings estab-
lish Ret and subsequent downstream effectors as critical
regulators of long-term maintenance of the nigrostriatal DA
system. Because similar alterations are observed in the early
phases of PD, DAT-Retlx/lx mice might be useful for gaining
insights into the molecular mechanisms involved in the
development of PD.
Figure 5. Gliosis in Dorsal Striatum of DAT-Retlx/lx Mice
(A, B, D, E, G, and H) Bright-field photomicrographs of dorsal striatum (A, B, D, and E) and SNpc (G and H) of 12-mo-old (A and B) and 24-mo-old (D, E, G,
and H) control (A, D, and G) and DAT-Retlx/lx mutants (B, E, and H) stained for GFAP.
(C, F, and I) Histograms showing the number of GFAP-positive reactive astrocytes (n¼ 3–5 per genotype). There is a 2-fold increase in the number of
reactive astrocytes in the striatum of 2-y-old DAT-Retlx/lx mutants as compared to wild-type controls and DAT-TrkBlx/lx mutants (F) (p , 0.0001), whereas
no difference is seen in 12-mo-old DAT-Retlx/lx mutants compared to controls (C) (p¼ 0.9). No significant increase in the number of reactive astrocytes is
seen in the SNpc of 24-mo-old DAT-Retlx/lx mutants compared to controls (I) (p ¼ 0.24). **, p , 0.01 (Student t-test). Scale bars indicate 50 lm.
doi:10.1371/journal.pbio.0050039.g005
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Ret and TrkB Are Dispensable for the Development of the
Nigrostriatal System
The apparently normal development and maturation of the
nigrostriatal system in DAT-Retlx/lx, DAT-TrkBlx/lx, and DAT-Ret/
TrkB mice was rather surprising in light of the known in vitro
neurotrophic effects of the respective ligands GDNF and
BDNF on DA neurons [9]. Consistent with our results,
transgenic overexpression of GDNF or knock-down of GDNF
in mice transiently altered the number of DA neurons in the
early postnatal days; however, these alterations did not persist
into adulthood (see [8] and references within). Ablation of the
BDNF gene in the developing mid-hindbrain region using
Wnt1-Cre–mediated recombination resulted in reductions in
the number of TH-positive neurons in the SN of newborn
mice [19]. In contrast to our study, BDNF ablation was earlier,
not cell-type specific, and more widespread (mid-hindbrain
region), and may have caused alterations in other non-DA
neurons and progenitor cells that influenced the develop-
ment of the nigrostriatal system.
Ret Is Required for Long-Term Maintenance of the
Nigrostriatal System
We found that Ret is specifically required for long-term
target innervation and cell survival of a significant fraction of
SNpc DA neurons. In aged Ret mutant mice, the extent of
target innervation loss exceeded the degree of cell loss. This is
consistent with observations from PD patients and MPTP-
treated animals, which led to the current model of a ‘‘dying
back’’ process to explain the DA neuron degeneration [4].
The requirement for Ret appears to be topographically
specific: The nigrostriatal pathway from SNpc to dorsal
striatum was more dependent on Ret than the mesolimbic
pathway from the VTA to ventromedial striatum. At first
glance, this seemed surprising because VTA neurons were
shown to be more responsive than SN neurons to overex-
pressed GDNF, and the number of VTA neurons, but not
SNpc neurons, persistently increased to adulthood in these
mice [33]. GDNF is the likely Ret ligand in this system,
because it promotes neurite outgrowth and sprouting of
adult midbrain DA neurons more efficiently than do related
family members [9,34], and its expression is maintained at
detectable levels in the adult [35]. This suggests that GDNF/
Ret signaling might be limiting, but not essential, for VTA
neurons.
Differences in sensitivity toward stresses between VTA and
SNpc neurons have been described previously. For example,
SNpc neurons are more sensitive than VTA neurons to 6-OH-
dopamine treatment and overexpression of human a-synu-
clein [36,37]. The presence of functional Kir6.2, a K-ATP
channel, promotes cell death of SNpc, but not VTA neurons
in two chronic mouse models of DA degeneration [38].
Aphakia mice, deficient for the transcription factor Pitx3
Figure 6. Inflammation in SNpc of DAT-Retlx/lx Mice
(A, B, D–I, K, and L) Immunohistochemical stainings of dorsal striatum (A and B) and SNpc (D–I, K, and L) of 24-mo-old control (A, D, E, H, and K) and DAT-
Retlx/lx mice (B, F, G, I, and L) for Iba-1 (A, B, E, G, H, and I), TH (D and F), and MAC1 (K and L). To localize microglial cells in SNpc, adjacent sections were
stained for TH, and the area of the SNpc was marked and copied to the adjacent section stained for macrophages.
(C, J, and M) Histograms showing the number of Iba-1–positive (C and J) and MAC1-positive (M) cells in the striatum (C) and SNpc (J and M) of 24-mo-
old (C and J) DAT-Retlx/lx mice and controls. No significant alterations in the numbers of Iba-1–positive cells were observed in the striatum of 24-mo-old
mutants and controls ([C] n¼ 4, p¼ 0.065). A significant increase in the numbers of Iba-1–positive cells was observed in the SNpc of 24-mo-old DAT-
Retlx/lx mice compared to controls (J) (n¼ 5, p , 0.05). The same result was obtained using MAC1 as a second independent microglial marker (M) (n¼ 3,
p , 0.05). *, p , 0.05 (Student t-test). Scale bars indicate 100 lm.
doi:10.1371/journal.pbio.0050039.g006
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with important function for the establishment of the DA cell
fate, preferentially lose SNpc, but not VTA neurons [32].
These data suggest different physiological features of SNpc
and VTA neurons in vivo, including possible differences in
their cell death pathways and survival factor requirements. It
is possible that other neurotrophic factors such as members
of the TGF-b superfamily of cytokines [39] or MANF [40] are
required for the survival of VTA neurons. Future genetic
experiments will hopefully help to answer this question. Also,
in PD patients and neurotoxin-based animal models of PD,
the nigrostriatal pathway is most affected [4]. The reason for
this specificity is not well understood, but it suggests that the
molecular death pathways activated in PD, by MPTP and by
loss of Ret, share similarities.
We also observed reduced levels of evoked dopamine
release, but not of total dopamine amounts in the striatum of
DAT-Ret mutants. With respect to total dopamine tissue
content, it appears that reductions are generally observed
when the majority of SNpc neurons are lost. For example, the
recently published En1þ/;En2/mutant mice [41] show more
than 60% loss of SNpc neurons and a 39% reduction in total
striatal dopamine content. The DAT-Ret mutants do not show
such a strong decrease in SNpc neurons and, not surprisingly,
have normal levels of total dopamine content. In contrast to
the En mutants, DAT-Ret mutants lose neurons during ageing
which leaves more time for compensatory mechanisms (En
mutants lose SNpc neurons before P15). The physiologically
more important reduction in dopamine release after electric
stimulation parallels the age-dependent loss of striatal
innervation. It also parallels changes in postsynaptic neurons
such as the decrease of DARPP-32 expression. Whether or not
postsynaptic neurons become atrophic or eventually die in
PD patients and animal models is not clear and has not been
studied in great detail. There is evidence that loss of DA
neurons in the basal ganglia or dopamine depletion can lead
to changes in the striatum, such as loss of spines and
glutamatergic synapses [42] and may eventually lead to cell
death [43]. The mild postsynaptic alterations observed in the
DAT-Retlx/lx mice are consistent with the idea that presynaptic
decrease in DA fibers can indirectly lead to pathological
changes in postsynaptic striatal neurons.
Apoptosis contributes to PD neuronal loss [44] and is the
predominant cell death mechanism of neurotoxin-based
models using prolonged administration of low doses of
MPTP, but the detection of apoptotic cells is difficult because
of the very low frequency of dying cells and their rapid
clearance from the tissue [4]. Apoptosis is most probably the
cell death mechanism underlying neurotrophic factor depri-
vation; although, due to the late and selective degeneration of
nigral DA neurons, we were unable to detect apoptotic cells
in DAT-Retlx/lx mice. What may the signaling pathways down-
stream of Ret be that maintain target innervation and
mediate cell survival? Besides the well-documented impor-
tance of the PI3K/AKT pathway for neuronal survival in
response to GDNF [7], GDNF also increases dopamine release
and influences synaptic transmission [45,46], and might
thereby influence the vulnerability of SNpc neurons. Axon
degeneration often begins with breakdown of microtubules
whose assembly and disassembly is regulated by microtubule-
associated proteins (MAPs) and may involve collapsin-
response-mediator-protein-2 (CRMP2). The expression of
CRMP2 is induced by GDNF [47], and CRMP2 promotes
axon growth and branching as a partner for tubulin
heterodimers [48]. Work is currently in progress to inves-
tigate the role of downstream mediators of Ret in maintain-
ing DA afferents and cell survival.
The Role of TrkB in the Nigrostriatal System
Using single-cell RT-PCR, we detected TrkB mRNA in only
50% of nigral DA neurons. Ablation of TrkB expression in
the majority of the TrkBþ;THþ pool in the SNpc did not cause
any morphological alterations. Moreover, under sensitized
conditions in the absence of GDNF/Ret signaling, the addi-
Figure 7. Reduced Dopamine Release in the Striatum of DAT-Retlx/lx Mice
(A) Total dopamine levels normalized to 2,3-dihydroxybenzoic acid (DHBA)
and expressed relative to the weight of wet striatum (grams) of 2-y-old
control mice (Retlx/lx), heterozygous Retlx/, heterozygous DAT-Ret lx/þ,
homozygous DAT-Retlx/lx, andDAT-TrkBlx/lxmice. Note theminor reduction
of total dopamine levels in all mice carrying the DAT-Cre knock-in
construct.
(B–E) Evoked dopamine release after electrical stimulation in the dorsal
striatum of control mice (Retlx/lx and Retlx/mice), heterozygous DAT-Retlx/
þmice, and homozygous DAT-Retlx/lx mice of 1 y (B and C) or 2 y (D and E)
of age. In both age groups, there is a significant decrease of released
dopamine in the mice carrying the DAT-Cre knock-in construct
compared to controls. There is a further significant decrease in the
homozygous DAT-Retlx/lx mice due to the lack of Ret (n¼ 5 per genotype,
p , 0.05, Student t-test). *, p , 0.05; **, p , 0.01 (Student t-test). (C and
E) Representative traces of single evoked dopamine release in different
control and mutant mice.
doi:10.1371/journal.pbio.0050039.g007
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tional reduction of TrkB did not cause significant alterations
beyond those evoked by lack of Ret alone. From these results,
we conclude that the physiological role of TrkB in the
nigrostriatal system is minor at best. Cell and fiber loss
reported in previous studies using nonconditional alleles of
TrkB [49,50] have to be interpreted with care, since several
TrkB-positive cell types in this region are not DA. The
discrepancies between constitutive and conditional mutants
may be partially due to non-cell autonomous effects from
cells outside the SNpc. Additional Cre lines and markers for
specific cell populations will have to be employed to settle the
issue completely.
Glial Responses in Ageing Ret-Deficient Mice
Activated glial cells (astrocytes and microglia) have been
associated with central nervous system (CNS) injuries and PD
[2,51]. It is a matter of debate, whether activated microglial
cells are neuroprotective by the release of trophic factors or
participate in the propagation of neurodegenerative pro-
cesses. The mechanisms that lead to microglial and astroglial
cell responses in PD patients are not understood. Here, we
found that Ret ablation resulted in gliosis in the striatum and
to microglial activation in the SNpc. What could be the
underlying mechanisms? First, degenerating axons may be a
stronger signal for astrocytes than for microglia. Such a
conclusion is based on previous studies on injured CNS
axons, including peripheral motor axons. It was found that
astrocytes participated in the removal of presynaptic bou-
tons, whereas microglial participation was not required for
this process (reviewed in [52]). Second, apoptotic CNS
neurons may be sending signals that preferentially activate
microglia. Previous studies have shown that axotomy of
retinal ganglion cells in adult rats leads to protracted
degeneration that can be delayed by the application of
compounds that suppress macrophage and microglia activity,
suggesting that the microglial system has a key role in
eliminating severed neurons in the CNS [53]. Third, there
may be intrinsic differences between striatum and SNpc that
result in gliosis versus microglia activation. In MPTP-treated
mice, the astrocytic reaction is consecutive to death of
neurons, and astrocyte accumulation is observed primarily in
the striatum rather than in the SNpc [44,54]. Likewise, in PD
patients, astroglial responses are generally weak and micro-
glial responses are dramatic in the SNpc; they culminate in
subregions that are most affected by the neurodegenerative
process (reviewed in [55]).
Are DAT-Retlx/lx Mice a Useful Genetic Model for
Nigrostriatal Pathologies?
The nigrostriatal pathologies following Ret ablation display
several features of presymptomatic PD including (1) specific
and progressive degeneration of the nigrostriatal pathway,
with adult onset (so far unique among genetic PD models), (2)
greater loss of DA neurons in SNpc than in VTA, (3) greater
degeneration of DA nerve terminals in dorsal than ventral
striatum, (4) the presence of substantial neuroinflammation
and gliosis, and (5) reduced levels of evoked dopamine release
in striatum.
However, our DAT-Retlx/lx mice are not a perfect model of
symptomatic PD since they lack several hallmarks of the
disease, the first being the lack of cytoplasmic inclusions
containing a-synuclein. This suggests that SNpc neuron cell
death occurs in the absence of a-synuclein aggregates similar
to MPTP-based models and PD cases caused by parkin
mutations [56]. The absence of behavioral deficits in DAT-
Retlx/lx mice could be explained by incomplete destruction of
the nigrostriatal pathway below the reported threshold level
for symptom appearance in human PD patients and the
presence of compensatory mechanisms maintaining DA
homeostasis [3]. The unaltered total amounts of striatal
dopamine in the aged DAT-Retlx/lx mice support the idea that
these mice are still in a phase in which dopamine-dependent
or -independent mechanisms stabilize the system. Genetic
experiments are in progress to investigate whether the
chronic GDNF deprivation stress in DAT-Retlx/lx mice would
make nigral DA neurons more susceptible to other cellular
stresses ultimately leading to a more complete destruction of
the nigrostriatal pathway. Preliminary data suggest that mild
transgenic overexpression of human mutant Ala30Pro a-
synuclein using the TH promoter did not aggravate the
defects seen in DAT-Retlx/lx mice (L. Aron, E. R. Kramer, P.
Kahle, C. Haass, and R. Klein, unpublished data).
DAT-Retlx/lx mutants may be useful in studies of age-related
neurodegeneration. Neurotrophins are thought to improve
the body’s resistance to neurodegeneration. Environmental
factors such exercise, dietary energy restriction, and cognitive
stimulation protect neurons against dysfunctions and death.
This may happen, in part, by induction of a mild stress
response that induces the production of BDNF and GDNF [6].
Mice that lack neurotrophin responses in specific neuronal
subpopulations should be excellent models to test these
hypotheses. DAT-Retlx/lx mutants could also be used for the
identification of biomarkers associated with the first phases
of nigrostriatal pathway degeneration. So far there is no
evidence that PD can be caused by mutations in the GDNF
and Ret gene because analysis of polymorphisms in the GDNF
and Ret gene have not shown any association with PD [57].
But perhaps GDNF/Ret signaling is reduced as a secondary
consequence in PD and leads to the increased vulnerability of
SNpc neurons. Further experiments are required to clarify
this issue. However, the physiological requirement of Ret
signaling for the maintenance of the nigrostriatal system is an
important issue, considering the potential for stem cell
therapy to replace DA neurons in PD patients, and argues
for further investigations toward optimizing the ongoing
clinical trials using activators of the Ret pathway as potential
therapy for PD.
Materials and Methods
Transgenic animals. The generation of floxed Ret (Retlx) [24], TrkB
(TrkBlx) [25], and DAT-Cre [26] alleles, and the Nestin-Cre transgenic
mice [27] was described previously. Cre mice were crossed with
ROSA26R reporter mice [58] to test for proper Cre expression. The
mice used in this study were kept on a C57Bl6/J genetic background
with contributions of 129/sv from the embryonic stem cell culture
and the different Cre mouse lines. Because both Cre lines show
significant recombination in germ cells, the floxed allele derived
from the parent that carries the Cre recombinase is often
constitutively recombined; therefore, the homozygous Ret mutants
carry one Ret allele recombined in a regionally specific manner and
one Ret allele recombined constitutively. Unless specifically men-
tioned, the control mice for all experiments carried floxed alleles of
Ret (Retlx/lx, Retlx/þ), TrkB (TrkBlx/lx, TrkBlx/þ), or one copy of Cre (DAT-
Cre or Nestin-Cre).
Histology and immunohistochemistry. For b-galactosidase stain-
ings, mice were perfused with PBS and 30% sucrose; for immuno-
histochemistry, mice were perfused with PBS and 4%
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paraformaldehyde. Subsequently, brains were removed from the
scull, postfixed overnight in the same fixative, and cyroprotected by
incubating them in 15% and 30% sucrose solutions. Left and right
brain halves were embedded separately in egg yolk with 10% sucrose
and 5% glutaraldehyde, and kept frozen at80 8C until analyzed. The
30 lm–thick coronal sections were cut on a cryostat, collected free
floating, and then directly used for stainings or stored in a
cryoprotection solution at 20 8C until utilized. For fluorescent
immunohistochemical stainings, sections were premounted; for all
other stainings, free-floating sections were used. Primary antibodies
used were goat anti-Ret (1:25; RDI, Flanders, New Jersey, United
States, or Neuromics, North Field, Minnesota, United States),
monoclonal mouse anti-tyrosine hydroxylase (1:2,000; DiaSorin,
Stillwater, Massachusetts, United States), rabbit anti-dopa decarbox-
ylase (1:100; Chemicon/Millipore, Billerica, Massachusetts, United
States), monoclonal mouse anti–b-galactosidase (1:50; Sigma, St.
Louis, Missouri, United States), rat anti-dopamine transporter
(1:500; Chemicon/Millipore), rabbit anti-Pitx3 (1:1,000, provided by
M. P. Smidt [29]), monoclonal mouse anti-NeuN (1:200; Chemicon/
Millipore), rabbit anti-GFAP (1:500; DakoCytomation, Glostrup,
Denmark), rabbit anti–DARPP-32 (1:50; United States Biological,
Swampscott, Massachusetts, United States), monoclonal mouse anti-
parvalbumin (1:10,000; Swant, Bellinzona, Switzerland), rabbit anti–
Iba-1 (1:1,000; Wako, Neuss, Germany), monoclonal rat anti-MAC1
(1:200; Serotec, Kidlington, United Kingdom). For diaminobenzidine
detection of the primary antibody, different Vectastain ABC kits
(Vector Laboratories, Burlingame, California, United States) were
used according to the provider’s instructions. For NeuN/TH double
labeling, we first stained for NeuN as described above, followed by a
weak TH staining with more-diluted primary (1:20,000) and secon-
dary antibodies (1:2,000) and avidin-HRP/biotin complexes (1:2,000).
DA fiber density in the striatum was assessed on every third section
spanning the striatum (between Bregma þ1.10 mm and 0.10 mm)
[59]. The mounted sections were blocked for 1 h in 5% BSA, 0.3%
Triton X-100 in TBS, and incubated with the first antibody diluted in
2% BSA, 0.1%Triton X-100 in TBS at 4 8C overnight. The sections
were washed three times in TBS for 5 min, incubated in biotinylated
secondary antibody (1:200 anti-mouse or anti-rat, Vectastain) for 2 h
at room temperature, again washed as described above, and treated
with streptavidin-Cy3 (1:500; Sigma) for 2 h. After another three
washing steps, sections were mounted in aqueous mounting medium
with anti-fading reagent (Biomedia, Foster City, California, United
States, or DakoCytomation), and pictures were taken with a
fluorescent microscope (Axioplan; Zeiss, Go¨ttingen, Germany) at
633. For every section, three pictures in the dorsal striatum and two
pictures in the ventral striatum were acquired. In order to automati-
cally delineate the fibers and to increase the signal-to-noise ratio, the
images were first thresholded and subsequently quantified with an
automatic counting-grid macro implemented in the Metamorph
software (Molecular Devices, Sunnyvale, California, United States).
Stereological countings were done with the StereoInvestigator
program (MicroBrightField, Williston, Vermont, United States) on
every third section for the LC and at least every sixth section for the
SNpc and VTA.
Biochemistry. For Western blot analysis from the substantia nigra
and the striatum and for total dopamine measurements in the
striatum, mouse brain tissue isolation was done by cutting 2 mm–
thick coronal sections (2-mm rostral or caudal to the interaural line)
from a freshly frozen brain and punching out 2-mm2 (substantia
nigra) or 3-mm2 (striatum) tissue circles with sample corers (Fine
Science Tools, Heidelberg, Germany). Western blot analysis was done
according to standard techniques with a rabbit anti-Ret (1:250; Santa
Cruz Biotechnology, Santa Cruz, California, United States) and a
mouse monoclonal anti–a-tubulin antibody (1:500; Sigma). Total
striatal dopamine was measured as described previously [60] with a
few modifications.
FSCV on brain slices. Evoked release of dopamine was measured in
200 lm–thick coronal slices containing the striatum of control mice
(Retlx/lx and Retlx/ mice), heterozygous DAT-Retlx/þ mice, and homo-
zygous DAT-Retlx/lx mice of 1 y or 2 y of age. The slice preparation was
done as previously described [32]. Dopamine release was evoked by a
single pulse (0–1,000 lA, 300 ls) applied through a bipolar
stimulation electrode (bipolar stainless steel, 100 lm, insulated
except for the tip) every 30 s. Dopamine was detected with 5-lm
carbon-fiber disk electrodes insulated with electrodeposition paint
(ALA Scientific Instruments, Westbury, New York, United States)
using FSCV. Cyclic voltammograms (ramps from 500 mV to þ1,000
mV and back to 500 mV versus a Ag/AgCl, 300 V/s) were repeated
every 100 ms using an EPC10 amplifier (HEKA Electronic, Lambrecht,
Germany). Stimulus-evoked dopamine overflow was measured by
subtracting the background current obtained before stimulation
(average of ten pre-stimulus responses) from the current measured
after stimulation, using IgorPro software (Wavemetrics, Lake Oswego,
Oregon, United States). The resulting voltammogram showed a
typical dopamine profile, with an oxidation peak between 500 and
700 mV and a smaller reduction peak around 300 mV. The
concentration of the dopamine overflow was calculated after
calibrating the recording electrode in known concentrations of
dopamine. The amount of dopamine released depends on the
stimulation intensity, and the input–output relation was fitted with
a sigmoid function [dopamine]/[dopamine]max ¼ 1/f1 þ exp[-(S.I.  S.I.1/2)/
k]g where S.I. ¼ stimulation intensity.
Supporting Information
Figure S1. Recombination of the Floxed TrkB Locus in DAT-TrkB
Mutant Mice
(A) PCR results on genomic DNA from tissue of the SNpc and
striatum (ST) of heterozygote Nes-TrkB mutant mice (Nes-TrkBlx/þ),
TrkB wild-type mice (TrkBþ/þ), and heterozygote DAT-TrkB mutant
mice (DAT-TrkBlx/þ) to detect the wild-type TrkB allele (TrkB wt), non-
recombined floxed TrkB allele (TrkB lox), and the recombined floxed
TrkB allele (TrkB lox rec). In Nes-TrkBlx/þ mice, we detected a strong
TrkB wt, a weak TrkB lox, and a strong TrkB lox rec band both in the
SNpc and ST, because Nes-Cre efficiently recombines the floxed TrkB
locus in most neurons. In TrkBþ/þmice, we detected only the TrkB wt
band. In DAT-TrkBlx/þ mice, the PCR strongly amplified the TrkB wt
and TrkB lox fragment from SNpc and ST genomic DNA. The TrkB
lox rec band is only visible in the PCR reaction with the genomic
DNA from SNpc, but not from ST, showing specific and efficient
recombination of the floxed TrkB allele in DA neurons expressing
Cre from the DAT locus.
(B) Coronal brain sections of the SNpc are shown before and after
laser microdissection. In the area of the SNpc, large cells were
selected, and single cells were collected for mRNA detection by RT-
PCR.
(C) Representative results of the single-cell RT-PCR for TH and TrkB
are shown from cells of control (TrkBþ/þ) and homozygous TrkB (DAT-
TrkBlx/lx) mutant mice.
(D) Quantification of the RT-PCR results. In controlmice, TrkBmRNA
was detected in approximately 50% of TH-positive cells. This number
was set to 100%. DAT-TrkBlx/lx mice showed a reduction of 65% of
TrkB;TH double-positive cells.
Found at doi:10.1371/journal.pbio.0050039.sg001 (1.4 MB PDF).
Figure S2. Quantification of Nissl-Stained Cells in the SNpc of DAT-
Retlx/lx Mice
(A) Coronal brain section of a 1-y-old wild-type mouse showing DA
neurons in the SNpc and the VTA labeled for both Nissl (blue) and
TH (brown).
(B) Higher magnification view of the boxed area of (A) showing the
presence of numerous cells labeled only by Nissl and not by TH. TH
staining was used to select the area for quantification.
(C) Stereological quantification of Nissl-stained cells in the SNpc of 1-
y-old controls and DAT-Retlx/lx mice (n ¼ 4 mice per genotype, p ¼
0.17). No significant differences between the number of Nissl-positive
cells in controls versus DAT-Retlx/lx mice were seen.
Found at doi:10.1371/journal.pbio.0050039.sg002 (1.5 MB PDF).
Figure S3. No a-Synuclein Accumulation in SNpc of 2-Y-Old DAT-
Retlx/lxand DAT-TrkBlx/lx Mice
Immunohistochemical detection of a-synuclein in SNpc using a
purified sheep polyclonal antibody (a-syn (1)) or a crude rabbit
antiserum (a-syn (2)). Both antibodies detected a-synuclein in SNpc
of 3-mo-old transgenic mice (B and D) overexpressing a-synuclein
under a TH promoter (TH-a-syn) but not in non-transgenic control
littermates (control) (A and C). However, the crude rabbit antiserum
previously used showed some unspecific cellular labeling (C) [49].
No a-synuclein accumulation was observed in 2-y-old control (E and
H), DAT-Retlx/lx (F and I), and DAT-TrkBlx/lx (G) mice. Again, the crude
rabbit antiserum showed some unspecific staining (H and I). Scale
bars indicate 100 lm.
Found at doi:10.1371/journal.pbio.0050039.sg003 (5.3 MB PDF).
Figure S4. Input–Output Curve of the FSCV Experiment
The amount of dopamine release in the FSCV experiment of 1-y-old
mice (A) and 2-y-old mice (B) depends on the stimulation intensity
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(SI). The input–output relation was fitted with a sigmoid function
[DA]/[DA]max ¼ 1/f1 þ exp (SI  SI1/2)/kg. The stimulation intensity
needed for half-maximal release in the striatum did not differ (12 mo:
Retlx/lx 48 6 6 lA, Retlx/ 52 6 3 lA, DAT-Retlx/þ 50 6 7 lA, and DAT-
Retlx/lx 54 6 8 lA; 24 mo: Retlx/lx 51 6 5 lA, Retlx/ 47 6 10 lA, DAT-
Retlx/þ 53 6 4 lA, and DAT-Retlx/lx 56 6 9 lA), which suggests that the
reduced DA output capacity in the Ret mutant mice is most likely due
to the reduced fiber density and not to a presynaptic excitability
function of Ret for regulating dopamine release.
Filled circle (), Retlx/lx; open circle (*), Retlx/; filled triangle (m), DAT-
Retlx/þ; open triangle (D), DAT-Retlx/lx.
Found at doi:10.1371/journal.pbio.0050039.sg004 (298 KB PDF).
Figure S5. Behavioral Analysis of DAT-Ret Mice
Mice older then 18 mo were tested in behavioral tests for general
activity (A and B) and motor deficiencies (C and D). The vertical
activity (rearing) of the mice was tested in open-field experiments (A);
the horizontal activity was analyzed in a forced swimming test (B).
The motor coordination was measured in a swimming tank (C) and a
rotarod test (D) (n . 15).
Found at doi:10.1371/journal.pbio.0050039.sg005 (166 KB PDF).
Protocol S1. Supplementary Materials and Methods
Found at doi:10.1371/journal.pbio.0050039.sd001 (56 KB PDF).
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